Open-Label Extension Study of Setmelanotide

This is an open-label extension study designed to evaluate the long-term safety and tolerability of continued setmelanotide treatment in male and female patients ≥2 years of age who have completed or ...

Lead sponsor: Rhythm Pharmaceuticals, Inc.•13 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 2/3

Long Term Extension Trial of Setmelanotide

NCT03651765 · Obesity Associated With Defects in Leptin-melanocortin Pathway

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 4, 2025Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

PhasePHASE3

Enrollment30

Start dateOct 2024

Last updatedSep 4, 2025

Locations shown

HonorHealth Research Institute

Scottsdale, Arizona

UC San Diego- Rady Children's Hospital

San Diego, California

University of Florida at Gainesville

Gainesville, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 4, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions